RxDoctor Payments DataLook up a doctor →

Paul Pickrell

Rheumatology · Austin, TXNPI 1114935418

Payments from drug & device makers

$40,946,626in general payments, 2019–2025

Across 8,880 payments — averaging $4611.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$21.8M
  • Pfizer$5.8M
  • AstraZeneca$4.3M
  • AbbVie$1.5M
  • Astrazeneca UK Limited$1.4M
  • Emergent Biosolutions Inc.$1.2M
  • plus $5M from 33 others
$4,735in research payments, 2019–2025

Across 12 payments — averaging $394.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$3K
  • GSK$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$17

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.5,361$21,816,650
Pfizer463$5,758,347
AstraZeneca22$4,295,594
AbbVie(2 entities)569$1,490,207
Astrazeneca UK Limited16$1,434,123
Emergent Biosolutions Inc.1,327$1,155,793
GSK264$1,079,188
Bavarian Nordic A/s108$858,068
Johnson & Johnson(2 entities)42$727,695
Janssen Research & Development, LLC66$443,774
Merck113$364,551
Novartis9$335,954
E.r. Squibb & Sons, L.L.C.17$201,745
Amgen(2 entities)166$198,633
Novavax Inc34$163,207
Takeda Pharmaceuticals U.S.A., Inc.28$147,463
Sanofi Pasteur Inc.24$110,591
Eli Lilly13$103,948
Genentech, Inc.26$71,562
Sun Pharmaceutical Industries Inc.100$61,090
Sanofi US Services Inc.8$35,585
Biogen1$28,716
Otsuka Pharmaceutical Development & Commercialization, Inc.1$20,769
Biohaven Pharmaceuticals, Inc.5$19,507
GRT US Holding, Inc.5$12,158
Astellas Pharma Global Development2$10,100
Lilly USA, LLC23$362
Boehringer Ingelheim15$338
Aurinia Pharma U.S., Inc.6$161
Sanofi8$147
Radius Health, Inc.8$137
Bristol Myers Squibb12$117
UCB, Inc.4$94
Genentech USA, Inc.4$79
Sanofi-aventis U.S. LLC4$75
Collegium Pharmaceutical, Inc.3$46
Mallinckrodt Hospital Products Inc.1$20
Kaleo, Inc.1$17
Mallinckrodt Enterprises LLC1$16

How this compares

$40,946,626 in reported general payments places this provider in the 95th percentile of 512 rheumatology providers in Texas.

See all rheumatology providers in Texas →

Other rheumatology in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →